Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation
Nikolaos Patsoukis(Beth Israel Deaconess Medical Center), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Anders H. Berg(Cedars-Sinai Medical Center), Jonathan S. Duke‐Cohan(Harvard University), Apoorvi Chaudhri(Harvard University), Gordon J. Freeman(Dana-Farber Cancer Institute), Halil‐Ibrahim Aksoylar(Beth Israel Deaconess Medical Center), Qi Wang(NSF NCAR High Altitude Observatory)
Cited by 170
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k